Breast cancer, with its myriad subtypes, has long eluded a uniform treatment strategy. The disease’s molecular complexity has rendered traditional, blanket treatments insufficient, particularly for the aggressive triple-negative form.
Novel PTSD Treatment Improved Symptom Severity in Phase IIb Trial
An investigational therapy for post-traumatic stress disorder (PTSD) improved symptom severity as soon as one month into a 12-week, phase IIb study. In a modified
December 9, 2024